2024

1. G Barabona, I Ngare, D Kamori, L Nkinda, Y Kosugi, A Mawazo, R Ekwabi, G Kinasa, H Chuwa, The Genotype to Phenotype Japan (G2P-Japan) Consortium, K Sato, B Sunguya, T Ueno: Neutralizing Immunity against Coronaviruses in Tanzanian Health Care Workers. Sci Rep, in press 2024

2. H Aoki, M Kitabatake, H Abe, P Xu, M Tsunoda, S Shichino, A Hara, N Ouji-Sageshima, C Motozono, T Ito, K Matsushima, S Ueha. CD8+ T-cell memory induced by successive SARS-CoV-2 mRNA vaccinations is characterized by shifts in clonal dominance. Cell Rep, in press, 2024

3. Y Tomita, S Sakata, K Imamura, S Iyama, T Jodai, K Saruwatari, S Hamada, K Akaike, M Anai, K Fukusima, A Takaki, H Tsukamoto, Y Goto, C Motozono, K Sugata, Y Satou, T Ueno, T Ikeda, T Sakagami: Association of Clostridium butyricum therapy using the live bacterial product CBM588 with the survival of patients with lung cancer receiving chemoimmunotherapy combination. Cancers 16, 47, 2024

4. Y Maeda, M Toyoda, T Kuwata, H Terasawa, U Tokugawa, K Monde, T Sawa, T Ueno, S Matsushita: Differential ability of S protein of SARS-CoV-2 variants to downregulate ACE2. Int. J. Mol. Sci, 25, 1353, 2024

5. E Nkuwi, G Judicate, TS Tan, G Barabona, M Toyoda, B Sunguya, D Kamori, T Ueno. Relative Resistance of Patient-derived Envelope Sequences to SERINC5-mediated Restriction of HIV-1 Infectivity. J Virol e00823-23, 2023

6. Toyoda M, Tan TS, Motozono C, Yonekawa A, Minami R, Nagasaki Y, Miyashita Y, Oshiumi H, Nakamura K, Ueno T. Evaluation of neutralizing activity against Omicron subvariants in BA.5 breakthrough infection and 3-dose vaccination using a novel chemiluminescence-based, virus-mediated cytopathic assay. Microbiol Spectr, e00660-23, 2023

7. T Mwakyandile; G Shayo; P Sasi; F Mugusi; G Barabona; T Ueno; E Lyamuya: Traditional Risk Factors for Cardiovascular Diseases and their Correlates among Treatment naïve HIV- infected Adults Initiating Antiretroviral Therapy in Urban Tanzania. BMC Cardiovascular Disorders 309, 2023

8. K Matsumoto, T Kuwata, W Tolbert, J Richard, S Ding, J Prévost, S Takahama, G Judicate, T Ueno, H Nakata, T Kobayakawa, K Tsuji, H Tamamura, A Smith, M Pazgier, A Finzi, S Matsushita. Characterization of a novel CD4 mimetic compound YIR-821 against HIV-1 clinical isolates. J Virol 97, e01638-22, 2023

9. J Rugemalila, D Kamori, P Kunambi, M Mizinduko, A Sabasaba, S Masoud, F Msafiri, S Mugusi, R Mutagonda, L Mlunde, D Amani, E Mboya, M Mahiti, G Ruhago, J Mushi, V Sambu, G Mgomella, B Jullu, W Maokola, P Njau, B Mutayoba, G Barabona, T Ueno, A Pembe, T Nagu, B Sunguya, S Aboud. HIV-1 virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: a cross sectional study in Tanzania. PLoS One 2023; 18(2):e0281528.

10. D Kamori, G Barabona, J Rugemalila, W Maokola, S Masoud, M Mizinduko, A Sabasaba, G Ruhago, V Sambu, J Mushi, G Mgomella, J McOllogi, F Msafiri, S Mugusi, J Boniface, R Mutagonda, L Mlunde, D Amani, E Mboya, M Mahiti, A Rwebembera, T Ueno, A Pembe, P Njau, B Mutayoba, B Sunguya. Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on antiretroviral therapy in Tanzania: Findings from a national representative HIV drug resistance survey. J Antimicrob Chemother. 2023: dkad010. doi: 10.1093/jac/dkad010